Pom Wonderful LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2002-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.pomwonderful.com
Clinical Trials
5
Active:0
Completed:5
Trial Phases
2 Phases
Phase 1:2
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (60.0%)Phase 1
2 (40.0%)A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Male Infertility
- First Posted Date
- 2012-05-10
- Last Posted Date
- 2012-05-14
- Lead Sponsor
- POM Wonderful LLC
- Target Recruit Count
- 12
- Registration Number
- NCT01595308
- Locations
- 🇺🇸
Clinical Trials Program at University of California, Los Angeles, California, United States
Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study
Phase 2
Completed
- Conditions
- Recurrent Prostate Cancer
- Interventions
- Drug: 1 POMx capsuleDrug: 3 POMx capsules
- First Posted Date
- 2010-10-14
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- POM Wonderful LLC
- Target Recruit Count
- 104
- Registration Number
- NCT01220817
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Pomegranate Extract Biomarker Study in Osteopenic Women
Phase 1
Completed
- Conditions
- Osteopenic Women
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2010-10-13
- Lead Sponsor
- POM Wonderful LLC
- Target Recruit Count
- 64
- Registration Number
- NCT01219140
- Locations
- 🇺🇸
SeaView Research, Inc., Miami, Florida, United States
POMx In the Treatment of Erectile Dysfunction
Phase 2
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Drug: PlaceboDrug: One POMx capsule dailyDrug: 2 POMx Capsules
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2012-10-05
- Lead Sponsor
- POM Wonderful LLC
- Target Recruit Count
- 120
- Registration Number
- NCT01220206
- Locations
- 🇺🇸
Medical Affiliated Research Center, Huntsville, Alabama, United States
Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection
Phase 2
Completed
- Conditions
- Common Cold
- First Posted Date
- 2008-04-09
- Last Posted Date
- 2008-08-18
- Lead Sponsor
- POM Wonderful LLC
- Target Recruit Count
- 150
- Registration Number
- NCT00655031
- Locations
- 🇺🇸
Accelovance Inc., Huntsville, Alabama, United States
🇺🇸Accelovance Inc, Melbourne, Florida, United States
🇺🇸University of Virginia School of Medicine, Charlottesville, Virginia, United States
News
No news found